共 50 条
The Role of Liver Transplantation in Hepatocellular Carcinoma
被引:0
|作者:
Jakhete, Neha
[1
]
Majeed, Nehna Abdul
[2
]
Maluf, Daniel
[3
]
Shetty, Kirti
[1
]
机构:
[1] Univ Maryland, Sch Med, Program Transplantat, Div Gastroenterol & Hepatol, 22 S Greene St,N3W50, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Div Gastroenterol & Hepatol, 22 S Greene St,N3W50, Baltimore, MD 21201 USA
[3] Univ Maryland Med Transplantat, Univ Surg, Dept Surg, 22 S Greene St, Baltimore, MD 21201 USA
关键词:
Hepatocellular carcinoma;
Liver transplantation;
Recurrence predictors;
WORKING GROUP-REPORT;
RETREAT SCORE;
TUMOR SIZE;
RECURRENCE;
INHIBITORS;
RECIPIENTS;
SIROLIMUS;
OUTCOMES;
IMMUNOTHERAPY;
MULTICENTER;
D O I:
10.1016/j.cld.2024.08.009
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
The role of LT for HCC has evolved and expanded in the 3 decades since it was first introduced. However, multiple challenges remain in terms of selecting those patients with the lowest recurrence risk. While several clinical prognostic models have been developed, application of these models is dependent on individual center practices. Precision oncology shows promise-the integration of molecular markers predicting tumor behavior, as well as therapeutic response could enable accurate prognostication and pre transplant therapy. Locoregional and systemic therapy has enabled patients with HCC to be "bridged" or "downstaged", expanding the indications for LT in HCC. With the availability of machine perfusion therapy the utilization of extended criteria donors is expected to increase exponentially. It is hoped that the expansion of the donor pool will meet the increased demand for LT in HCC, while also mitigating disparities in access to transplantation.
引用
收藏
页码:73 / 85
页数:13
相关论文